Cancer drugs in development U.S. number 2005-2018

Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

This statistic depicts the number of cancer drugs in development in the United States in select years between 2005 and 2018. As of May 2018, over 1,100 cancer drugs in development were reported. All of the medicines are either in clinical trials or awaiting review by the Food and Drug Administration (FDA).

Number of cancer drugs in development in the United States in select years between 2005 and 2018

Characteristic	Number of cancer drugs
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

May 2018

More information

Region

United States

Survey time period

2005 to 2018

Special properties

PhRMA members

Supplementary notes

All of the medicines are either in clinical trials or awaiting review by the Food and Drug Administration (FDA). No data for 2010 and 2013 available. This statistic was assembled from several publications of PhRMA.
* Taken from PhRMA - Medicines in development for cancer (October 2014).
** Taken from PhRMA - Medicines in development for cancer (October 2015).
*** Taken from PhRMA - Medicines in development for cancer (May 2018).

Open this statistic in...

Spanish

Citation formats